cam a22 u 4500 128610794 CHVBK 20200921121543.0 880212s1981 at | 10 |eng|d 0-12-683820-8 (OCoLC)636387374 (NEBIS)000256091 ETH-BIB ger ETH-BIB ETHICS-ISBD 616.9 94 061 18 616.99/4 Tattersall M.H.N. Nucleosides and cancer treatment rational approaches to antimetabolite selectivity and modulation : proceedings of a symposium, Sydney, October 1980 ed. by M.H.N. Tattersall, R.M. Fox Sydney Academic Press 1981 XIX, 442 p. fig.; tab.; diagr. Ludwig symposi 2 2 (NEBIS)000015245 126711232 Cancer Chemotherapy Congresses Cancer Chemotherapy Congresses Nucleosides Congresses Nucleosides Congresses Metabolism Nucleosides Congresses Therapeutic use Nucleosides Metabolism Congresses Nucleosides Therapeutic use Congresses KREBSHEMMENDE ARZNEIMITTEL (PHARMAZIE) ger (ETHUDK)000026738 ethudk NUKLEOSIDE (BIOCHEMIE) ger (ETHUDK)000021870 ethudk Konferenzschrift Sydney (NSW) 1980 gnd-content u Antimetabolit / Kongresse, Konferenzen, Symposien idszbz Z9 u Krebs (Medizin) / Therapie / Chemotherapie / Kongresse idszbz Z9 u Nucleoside / Kongresse, Konferenzen, Symposien idszbz Z9 u KREBSHEMMENDE ARZNEIMITTEL (PHARMAZIE) ger 615.277.3 nebis E1 u NUKLEOSIDE (BIOCHEMIE) ger 577.113.3,2 nebis E1 u CARCINOSTATICS + ANTINEOPLASTICS + ONCOSTATICS + CANCER REMEDIES (PHARMACY) eng 615.277.3 nebis E1 u ONCOSTATIQUES + CARCINOSTATIQUES + ANTINÉOPLASTIQUES (PHARMACIE) fre 615.277.3 nebis E1 u NUCLÉOSIDES (BIOCHIMIE) fre 577.113.3,2 nebis E1 u NUCLEOSIDES (BIOCHEMISTRY) eng 577.113.3,2 nebis E1 BK020800 XK020000 XK020000 Sydney (NSW) Kongress = Congrès 1980 NEBIS Z01 Z01 04 TE 3118: 2 NEBIS E16 E16 RH P 516078: 2 NEBIS 100 1- Tattersall M.H.N. NEBIS 490 -- Ludwig symposi 2 2 (NEBIS)000015245 126711232